Lazard

• 

  Pharmaceutical Patent Ruling Pinches Opportunities in Emerging Markets

  By Marlene Y. Satter, AdvisorOne  |  May 9, 2013

  The decision by an Indian court not to grant a new patent to drug firm Novartis for a modified form of its cancer drug Glivec was a heavy blow to the company.

• 

  JPMorgan Tops M&A Charts for Q1

  By Janet Levaux, AdvisorOne  |  April 4, 2013

  BofA comes in third as Morgan Stanley sees its mergers business drop, according to Mergermarket.

• 

  Ouch! DoubleLine Raids TCW Again for More Talent

  By Janet Levaux, AdvisorOne, Joyce Hanson, AdvisorOne  |  March 22, 2013

  The focus has now turned to equity analysts, as the fixed-income shop makes a push to broaden its investment horizons.

• 

  New Hire Roundup: BlackRock Names Shedlin CFO

  By Marlene Y. Satter, AdvisorOne  |  February 20, 2013

  This week in new hires, Gary Shedlin was named CFO of BlackRock, and Mary Justice was named Seattle market leader for the Private Client Reserve of U.S. Bank.

• 

  Jefferson National Adds Alternative Investments to Help ‘Fiscal Cliff’ Anxiety

  By John Sullivan, AdvisorOne  |  November 29, 2012

  More than 68% of advisors have increased their use of alternative investments.

• Dutch Bailouts of ING, ABN Amro ‘Large Errors’: Committee

  By Marlene Y. Satter, AdvisorOne  |  April 11, 2012

  A parliamentary committee in the Netherlands said that the country’s government made “large errors” when it bailed out ING Groep NV, ABN Amro Holding NV and Fortis in 2008 and 2009, and those errors put taxpayers on the hook for greater risk and cost.

• 

  Compensation Spending Down at Goldman, Up at Smaller Firms

  By Janet Levaux, AdvisorOne  |  March 29, 2012

  Goldman Sachs ended 2011 with one of the lowest compensation-to-revenue ratios of the publicly traded investment banks, 42%, according to SNL Financial analysis.

• 

  Ezrati, Golub See Flat Investment Year of Risk-On Trades: IMCA 2012

  By Joyce Hanson, AdvisorOne  |  January 30, 2012

  Lord Abbett’s Milton Ezrati and UBS’ Jonathan Golub discussed investment strategies for 2012 at the IMCA conference in New York on Monday.

• 

  Mary Callahan Erdoes: Learning, and Teaching, by Example—Top Women Extended Profile

  By Marlene Y. Satter, AdvisorOne  |  July 25, 2011

  Mary Callahan Erdoes is known for working hard and standing up for what she believes.

• Lazard Offers New Services to Hedge Clients

  By Marlene Y. Satter, AdvisorOne  |  October 13, 2010

  Eagle Investment Systems, a subsidiary of BNY Mellon, announced Tuesday that Lazard Capital Markets' Prime Services division has deployed Eagle's suite of services designed for Lazard's hedge fund brokerage clients.